Table 2.
Targets | Clones | BC Loop (26–30) | FG Loop (77–81) | Framework Mutations | Affinity (nM) | |
---|---|---|---|---|---|---|
ELISA | ITC | |||||
CDC34 | 1D10 | CGLWC | PGLRL | S17I, T76I | <50 | N/D |
COPS5 | 1D7 | RRWDV | WGIII | None | <10 | N/D |
MAP2K5 | 1C4 | CRKCL | RLEWL | P51H, K83N | 6 | 11 |
2C12 | CRKCL | RLEFL | None | 17 | 6 | |
SF3A1 | 1E2 | ALPVY | VWWYE | None | <50 | N/D |
USP11 | 1C2 | WWVPQ | PGIYQ | L18M, G61C, G65D, S82I | N/D | 4 |
1A9 | WWSVP | PGIYA | D67V, S82I, Y92C | 52 | N/D |
BC and FG loops are the variable regions. Estimated affinities were determined by competition; phage ELISA and/or isothermal titration calorimetry (ITC). N/D: experiments were not; performed to determine the values.